Vidaza and confusional state Patient Reports February 11, 2012

Vidaza Side Effects Report #4867941-2
Vidaza side effect was reported by a Physician from SWITZERLAND on Dec 16, 2005. Male patient, 81 years of age, weighting 172.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: aortic arteriosclerosis, atrial fibrillation , cerebrovascular accident, condition aggravated, confusional state, embolism, fall , performance status decreased, renal impairment. Vidaza dosage: 120 MG (120 MG, ONCE DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with ATENOLOL, TORASEMIDE, FOLIC ACID. Patient was hospitalized. Patient recovered.

Vidaza Side Effects Report #4906736-8
Vidaza side effect was reported by a Physician from UNITED STATES on Jan 25, 2006. Male patient, 80 years of age, weighting 180.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatinine increased, blood potassium increased, confusional state, depressed level of consciousness, dyspnoea, international normalised ratio increased, lethargy. Vidaza dosage: 75 MG/M2, SUBCUTANEOUS. During the same period patient was treated with WARFARIN, DIGOXIN, FUROSEMIDE, MODAFINIL, ESZOPICLONE. Patient was hospitalized. Patient recovered.

Vidaza Side Effects Report #5838395-4
Vidaza side effect was reported by a Physician from UNITED STATES on July 24, 2008. Female patient, 78 years of age, weighting 163.1 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: appendiceal abscess, appendicitis perforated, bacterial culture positive, cellulitis , confusional state, diarrhoea, escherichia infection, neutropenia, post procedural complication. Vidaza dosage: (100 MG/M2, DAILY X 5 DAYS), INTRAVENOUS. During the same period patient was treated with METFORMIN, MECLIZINE, ACYCLOVIR, NAPROXEN, LUMIGAN EYE DROPS, COSOPT. Patient was hospitalized. Patient recovered.

Vidaza Side Effects Report #5663639-1
Vidaza side effect was reported by a Physician from UNITED KINGDOM on Feb 27, 2008. Female patient, 72 years of age, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: confusional state, lower respiratory tract infection, neutropenic sepsis. Vidaza dosage: (130 MG, DAILY X 5 DAYS), SUBCUTANEOUS. During the same period patient was treated with VALPROATE, THEOPHYLLINE. Patient was hospitalized. Patient died on 09/03/2007.


Vidaza Side Effects Report #5889276-1
Vidaza side effect was reported by a Physician from UNITED STATES on Sept 03, 2008. Female patient, 63 years of age, weighting 125.7 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: anal abscess, anal fistula, blood pressure diastolic decreased, body temperature decreased, confusional state, dehydration, febrile neutropenia, haemoglobin decreased. Vidaza dosage: (100 MG/M2, DAILY X 5 DAYS), INTRAVENOUS. Patient was hospitalized. Patient recovered.

Vidaza Side Effects Report #5626392-3
Vidaza side effect was reported by a Physician from GERMANY on Feb 01, 2008. Female patient, 68 years of age, weighting 94.80 lb, was diagnosed with acute myeloid leukaemia and was treated with Vidaza. After drug was administered, patient experienced the following side effects: agranulocytosis, anaemia, cachexia, confusional state, diarrhoea, leukoencephalopathy, thrombocytopenia. Vidaza dosage: (75 MG/M2, DAILY X7 DAYS), SUBCUTANEOUS. Patient was hospitalized. Patient recovered.

Vidaza Side Effects Report #6076036-4
Vidaza side effect was reported by a Physician from GERMANY on Jan 24, 2009. Female patient, 60 years of age, was treated with Vidaza. After drug was administered, patient experienced the following side effects: confusional state. Vidaza dosage: unknown. Patient recovered.